Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
mFOLFOX7 and Cetuximab for Liver-Metastatic Colorectal Cancer
NCT00803647Phase 2Completed
- Sponsor
- NSABP Foundation
- Start
- Jan 2010
- Primary completion
- Jul 2013
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 2, open-label trial of KL-140 in colorectal adenocarcinoma, sponsored by NSABP Foundation. Started Jan 2010; status: completed.
02
Drugs
KL-140
03
Conditions
colorectal adenocarcinoma
Beyond the preview
Go deeper on NCT00803647.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00803647.